Cocrystal Pharma Inc. (COCP) Financials Nov 14, 20
Post# of 250675
Posted On: 11/17/2014 3:17:44 AM
Cocrystal Pharma Inc. (COCP) Financials Nov 14, 2014, 3:55 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cocrystal Pharma Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 12.61M 17.19M 0
Cost of Goods Sold (COGS) incl. D&A 336 336 9.33M 9.97M 138,655
COGS excluding D&A 0 0 8.64M 9.49M 0
Depreciation & Amortization Expense 336 336 692,252 483,366 138,655
Depreciation 336 336 - - -
Amortization of Intangibles 0 0 - - -
Gross Income (336) (336) 3.27M 7.22M (138,655)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 41,075 48,897 7.16M 7.86M 3.16M
Research & Development - - 399,624 743,091 17,499
Other SG&A 41,075 48,897 6.76M 7.12M 3.14M
Other Operating Expense 1,437 260 0 0 0
Unusual Expense - - 281,508 1.85M 4.53M
EBIT after Unusual Expense - - (281,508) (1.85M) (4.53M)
Non Operating Income/Expense 244 83 0 0 (470,454)
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - (42,677) 0 0
Interest Expense - - 1.24M 5.48M 3.34M
Gross Interest Expense - - 1.24M 5.48M 3.34M
Interest Capitalized - - 0 0 0
Pretax Income (42,604) (49,410) (5.45M) (7.96M) (11.64M)
Income Tax 0 0 3,272 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - 3,272 - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (42,604) (49,410) (5.46M) (7.96M) (11.64M)
Minority Interest Expense (1,234) (932) 0 0 0
Net Income (41,370) (48,478) (5.46M) (7.96M) (11.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 (7.98M)
Extra Items & Gain/Loss Sale Of Assets - - 0 0 666,592
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 (8.65M)
Net Income After Extraordinaries (41,370) (48,478) (5.46M) (7.96M) (19.62M)
Preferred Dividends 0 0 0 0 4.14M
Net Income Available to Common (41,370) (48,478) (5.46M) (7.96M) (15.78M)
EPS (Basic) (0.01) (0.01) (0.11) (0.13) (0.34)
Basic Shares Outstanding 3.77M 3.77M 50.44M 62.03M 72.5M
EPS (Diluted) (0.01) (0.01) (0.11) (0.13) (0.34)
Diluted Shares Outstanding 3.77M 3.77M 50.44M 62.03M 72.5M
EBITDA (42,512) (49,157) (3.19M) (153,195) (3.16M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cocrystal Pharma Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 12.61M 17.19M 0
Cost of Goods Sold (COGS) incl. D&A 336 336 9.33M 9.97M 138,655
COGS excluding D&A 0 0 8.64M 9.49M 0
Depreciation & Amortization Expense 336 336 692,252 483,366 138,655
Depreciation 336 336 - - -
Amortization of Intangibles 0 0 - - -
Gross Income (336) (336) 3.27M 7.22M (138,655)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 41,075 48,897 7.16M 7.86M 3.16M
Research & Development - - 399,624 743,091 17,499
Other SG&A 41,075 48,897 6.76M 7.12M 3.14M
Other Operating Expense 1,437 260 0 0 0
Unusual Expense - - 281,508 1.85M 4.53M
EBIT after Unusual Expense - - (281,508) (1.85M) (4.53M)
Non Operating Income/Expense 244 83 0 0 (470,454)
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - (42,677) 0 0
Interest Expense - - 1.24M 5.48M 3.34M
Gross Interest Expense - - 1.24M 5.48M 3.34M
Interest Capitalized - - 0 0 0
Pretax Income (42,604) (49,410) (5.45M) (7.96M) (11.64M)
Income Tax 0 0 3,272 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - 3,272 - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (42,604) (49,410) (5.46M) (7.96M) (11.64M)
Minority Interest Expense (1,234) (932) 0 0 0
Net Income (41,370) (48,478) (5.46M) (7.96M) (11.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 (7.98M)
Extra Items & Gain/Loss Sale Of Assets - - 0 0 666,592
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 (8.65M)
Net Income After Extraordinaries (41,370) (48,478) (5.46M) (7.96M) (19.62M)
Preferred Dividends 0 0 0 0 4.14M
Net Income Available to Common (41,370) (48,478) (5.46M) (7.96M) (15.78M)
EPS (Basic) (0.01) (0.01) (0.11) (0.13) (0.34)
Basic Shares Outstanding 3.77M 3.77M 50.44M 62.03M 72.5M
EPS (Diluted) (0.01) (0.01) (0.11) (0.13) (0.34)
Diluted Shares Outstanding 3.77M 3.77M 50.44M 62.03M 72.5M
EBITDA (42,512) (49,157) (3.19M) (153,195) (3.16M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)